Date

November 06, 2020

Location

Live Sessions

Cell Science 2020 Webinar Overview


After the grand success of Cancer Biology 2019, Larix International Pte Ltd is proudly announcing International Webinar on Cancer Biology and Cell Science which is going to be held on November 06th, 2020 with the theme, Enlightening latest advancements in cancer diagnosis and therapy

Cell Science 2020 provides a vibrant platform for sharing knowledge among the Oncologists, haematologists, research scholars, students who are working in this field to exchange their knowledge related to Oncology Research. The workshops are designed for academia and industrial benefits who want to have updated knowledge on management and treatment techniques. The Webinar gathers expert surgeons in the world to share their experience and guide participants to explore advanced surgical techniques.

  • Best Oral Presentation Award
  • Poster Presentation Award
  • Young Research Forum
  • 3 Minutes thesis
  • Network with hundreds of attendees and see how they’re addressing challenges.
  • Experience the most respected additive Webinar, with over 20+ knowledgeable speakers.
  • Collaborate with users to advance applications for technologies.

IMPORTANT DATES


  • Abstract Submission opens:

    June 01,2020


  • Abstract Submission Deadline:

    October 26, 2020


  • Standard Registration opens:

    June 05,2020


  • Standard Registration Deadline:

    October 30, 2020

  • Session 1: Cancer Biology

Cancer systems biology encompasses the application of systems biology approaches to cancer analysis, so as to check the sickness as a complex adaptive system with rising properties at multiple biological scales. Cancer systems biology represents the application of systems biology approaches to the analysis of how the intracellular network of traditional cells are rattled during carcinogenesis to develop effective predictive models that can assist scientists and clinicians in the validations of new therapies and drugs. Tumours are characterized by genomic and epigenetic instability that alters the functions of many different molecules and networks in a single cell as well as altering the interactions with the local environment. Cancer systems supports the utilization of process and mathematical strategies to decipher the complexness in tumorigenesis additionally as cancer heterogeneousness.

  • Session 2: Cancer Diagnosis

 

Cancer is considered to be the main reason for deaths across the world.

The cure for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages.

So cancer identification becomes a really necessary a part of associate individual’s survival. Since the cancer cells exhibit properties of a normal cell until it reaches malignant stages, it becomes difficult to diagnose. However few symptoms will act just like the signals for the cancer growth. Once these symptoms are encountered one can endure diagnosing techniques like diagnostic test, Radiography etc. Through these strategies, the practician are going to be ready to predict the stage of cancer and survivability of the patients.

  • Session 3: Cancer Immunotherapy & Vaccine

 

Cancer therapy (Immuno-oncology or Immunooncology) is that the use of the system to treat cancer. Immunotherapies can be categorised as active, passive or hybrid (active and passive). These approaches exploit the very fact that {can|which will|that may}cer cells usually have molecules on their surface that can be detected by the immune system, called tumour-associated antigens (TAAs); they're often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the system to attack growth cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

  • Session 4: Cancer Biomarkers

                                            

Protein Biomarkers are often used as biomarkers for early detection of cancers particularly used for the identification of carcinoma.

Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if asuspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a diagnostic test are undertaken to verify carcinoma by H&E pathological analysis.

The presence of cancerous cells via pathology is extremely difficult because of high numbers of non-cancerous stromal infiltrating cells and administration of therapy or enrolment into a clinical test\ will only begin on definitive diagnosing of carcinoma.

These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 is known as a sensitive (98%) ANd specific (95%) IHC marker for carcinomaand gas-discharge tube is seeking a partner to develop an IHC primarily based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

  • Session 5: Translational Oncology

 

Translational Oncology is the field of Cancer Research where a series of research conducted at the labs come out with a novel approach towards the cancer therapy. This branch of science involves many interdisciplinary subjects. Researchers here will have to be familiar with all the knowledge. This is considered to be the next big thing in Cancer Research with great no of employability and Commercial opportunities available. Translational research has advanced from recognizing a solitary change driving genome to the high-throughput cutting edge entire genome sequencing investigations. Late advances in Omics have expanded our insight into the procedures underlying malignancy development

  • Session 6: Radiation Oncology

 

It is one among the 3 basic specialties, the opposite 2 being surgical and therapeutic medical specialty, related with the treatment of development.

Radiation can be given as a therapeutic system, either alone or in combine with surgery or probably therapy. The mission of Advances in Radiation Oncology is to give unique clinical research went for improving the lives of people living with tumour and distinctive ailments treated with radiation treatment.  Radiation Therapy, Predictive Oncology, Cancer Imaging, Stem Cell Therapy, Oncology Nursing

  • Session 7: Cancer Metabolism

 

Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most conventional tissue cells. Metabolic alterations in cancer cells are various and include aerobic glycolysis, reduced biological process and also the multiplied generation of synthesis intermediates required for cell growth and proliferation.

  • Session 8: Cancer Diagnosis

 

Cancer is considered to be the main reason for deaths across the world.

The cure for cancer is still a matter of research. However, there are few curing techniques available only if the person is diagnosed at the early growth stages. So cancer identification becomes a really necessary a part of associate individual’s survival. Since the cancer cells exhibit properties of a normal cell until it reaches malignant stages, it becomes difficult to diagnose. However few symptoms will act just like the signals for the cancer growth. Once these symptoms are encountered one can endure diagnosing techniques like diagnostic test, Radiography etc. Through these strategies, the practician are going to be ready to predict the stage of cancer and survivability of the patients.

  • Session 9: Cancer Immunotherapy & Vaccines

 

Cancer therapy (Immuno-oncology or Immunooncology) is that the use of the system to treat cancer. Immunotherapies can be categorised as active, passive or hybrid (active and passive). These approaches exploit the very fact that {can|which will|that may}cer cells usually have molecules on their surface that can be detected by the immune system, called tumour-associated antigens (TAAs); they're often proteins or other macromolecules (e.g. carbohydrates). Active immunotherapy directs the system to attack growth cells by targeting TAAs. Passive immunotherapies enhance existing anti-tumor responses and include the use of monoclonal antibodies, lymphocytes and cytokines.

  • Session 10: Cancer Biomarkers

 

Protein Biomarkers are often used as biomarkers for early detection of cancers particularly used for the identification of carcinoma. Diagnostic Patients with suspected pancreatic cancer will undergo an initial CT scan to determine if asuspect mass is localized and removed by surgery 63% of patients will be diagnosed with non-resectable stage III and IV disease and a diagnostic test are undertaken to verify carcinoma by H&E pathological analysis. The presence of cancerous cells via pathology is extremely difficult because of high numbers of non-cancerous stromal infiltrating cells and administration of therapy or enrolment into a clinical test will only begin on definitive diagnosing of carcinoma. These will notice specifically stains neoplastic pancreatic cells would enable the pathologist to confidently diagnose pancreatic cancer and thus offer appropriate cancer treatment to the patients. The Novel Biomarker BI-010 is known as a sensitive (98%) ANd specific (95%) IHC marker for carcinomaand gas-discharge tube is seeking a partner to develop an IHC primarily based test to detect BI-010 in fine needle aspirate biopsies from biopsy samples.

Session 11: Translational Oncology

 

Translational Oncology is the field of Cancer Research where a series of research conducted at the labs come out with a novel approach towards the cancer therapy. This branch of science involves many interdisciplinary subjects. Researchers here will have to be familiar with all the knowledge. This is considered to be the next big thing in Cancer Research with great no of employability and Commercial opportunities available. Translational research has advanced from recognizing a solitary change driving genome to the high-throughput cutting edge entire genome sequencing investigations. Late advances in Omics have expanded our insight into the procedures underlying malignancy development.

  • Session 12: Radiation Oncology

 

It is one among the 3 basic specialties, the opposite 2 being surgical and therapeutic medical specialty, related with the treatment of development. Radiation can be given as a therapeutic system, either alone or in combine with surgery or probably therapy. The mission of Advances in Radiation Oncology is to give unique clinical research went for improving the lives of people living with tumour and distinctive ailments treated with radiation treatment. Radiation Therapy,   Predictive Oncology, Cancer Imaging, Stem Cell Therapy, Oncology Nursing.

  • Session 13: Cancer Metabolism

 

Cancer metabolism refers to the alterations in cellular metabolism pathways that are evident in cancer cells compared with most conventional tissue cells. Metabolic alterations in cancer cells are various and include aerobic glycolysis, reduced biological process and also the multiplied generation of synthesis intermediates required for cell growth and proliferation.

  • Session 14: Cancer Epigenomics

 

Cancer epigenetics means studying of epigenetic modifications to genome of cancer cells that do not involve a change in the nucleotide sequence. Epigenetic corrections are important like genetic alterations, transition of a cell from normal to tumorous, and their manipulation holds great promise for cancer prevention, detection and therapy. In different cancers, a diversity of epigenetic mechanisms can be perturbed, such as silencing of tumor suppressor genes and activation of oncogenes by altered CpG island methylation patterns, histone modifications and dysregulation of DNA binding proteins.

  • Session 15: Cancer genomics

 

• Epigenetic influence on genomic stability

• Molecular underpinnings of therapeutic targets

• Aberrant DNA methylation genes

• Tumor heterogeneity

  • Session 16: Cancer Inflammation and Immune Tolerance

 

It is widely believed that chronic inflammation critically adds to cancer. Immune tolerance in cancer intermediates tumour escape from the immune system. Inflammation mediates tumor-induced tolerance. The induction and maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.

  • Session 17: Nanoparticles in Cancer Therapy

 

Since last decade nanoparticles have been of significant interest as they offer great benefits in drug delivery to overcome limitations present in case of conventional chemotherapy. Sizes ranges from (1-1000 nm) and also made by using a variety of materials including polymers, lipids, inorganic materials and biological materials. Targeted particles are used which are nano range to carry chemotherapeutic agents in cancer therapy, offers many advantages to improve drug/gene delivery and to overcome many problems associated with conventional chemotherapy.

  • Session 18: Novel Approaches to Cancer Therapeutics

 

The standard management modalities are associated with severe side effects and high toxicity which in turn lead to low quality of life. This encompasses novel strategies for more effective chemotherapeutic delivery aiming to generate better prognosis. Cancer treatment is a dynamic field and significant advances are being made in the development of novel cancer treatment strategies. The difference to conventional cancer therapeutics, novel approaches such as ligand or receptor based targeting, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic drug targeting and ultrasound-mediated drug delivery, have extra new modalities for cancer treatment.

  • Session 19: Cancer Epigenetics

 

• Molecular Profiling Techniques

• New Biologics & Vaccines

• Chemical Proteomics

• Combination Strategies in Immuno-oncology

• Novel Biomarker Discovery

  • Session 20: Cancer Prevention & Therapy

 

Malignancy treatment represents the treatment of tumour in a patient, regularly with surgery, chemotherapy or potentially radiotherapy. Treatments are likewise available for some disease composes. A malignancy subject may get a wide range of treatment, including those going for mitigating the manifestations of disease, for example, torment. Chemotherapy, as a rule, alludes to the utilization of pharmaceuticals or medications to treat disease. The possibility of having chemotherapy panics numerous individuals. Be that as it may, realizing what chemotherapy is, the manner by which it works and what's in the store can frequently help quiet your feelings of trepidation. It can likewise can be superior of controlling over your disease treatments. Directed treatment is a unique sort of chemotherapy that exploits the contrast between typical cells and malignancy cells. It's infrequently applied alone, however, frequently other malignancy medications are utilized with a focused treatment.

Testimonials


Attended by Industry Leaders


Facebook
Pinterest
Twitter
LinkedIn
blog Blog
Youtube